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We have recently described (1-3) a non-neoplastic lymphoproliferative disease
in C57BL/6 mice infected as adults with the LP-BM5 murine leukemia virus
(MuLV) mixture originally isolated by Laterjet and Duplan (4). This disease has
many of the features of the acquired immunodeficiency syndrome (AIDS),
including polyclonal B lymphocyte activation, hypergammaglobulinemia, lymph-
adenopathy, and profound immunodeficiency (1-6). The retroviral origin of the
murine disease and the striking similarities in immunologic abnormalities to
AIDS lead us to use the abbreviations MAIDS (murine acquired immunodefi-
ciency syndrome) for the LP-BM5 MuLV-induced immunodeficiency disease. In
man, the human immunodeficiency viruses (HIV) are thought to cause immu-
nologic abnormalities by depleting CD4' helper T cells (7, 8) and by directly
activating B cells (9). In mice, LP-BM5 MuLV infection is known to decrease
helper T cell function (1), but it is unclear whether alterations in T cell function
are related to the observed B cell hyperactivity. Since polyclonal activation of B
cells normally precedes loss of helper T cell function in both AIDS and MAIDS,
and because normal B cell activation is dependent upon a series ofT cell-derived
lymphokines (10-13), it is possible that the initial effects of retroviral infection
include a polyclonal activation of helper T cells that in turn act to stimulate B
cells. We have examined these issues by studying the course of MAIDS in T cell-
deficient athymic C57BL/10 nu/nu mice.
Materials and Methods
Mice.
￿
C57BL/ION mice heterozygous for the nude mutation were obtained from the
Division of Research Resources, NIH, and maintained under specific pathogen-free
conditions. Homozygous nu/nu offspring or nu/+ littermates were used at 8-16 wk of
age.
Virus. A freshly-thawed suspension of LP-BM5 MuLV containing 3 X 104 PFU
ecotropic MuLV and 4 X 10' mink cell focus-forming units (MCF) MuLV was injected
intraperitoneally in a volume of 0.5 ml. This dose of virus is ^-10-fold greater than that
required to cause disease in 100% of normal C57BL/10 mice.
TCell Reconstitution.
￿
107nylon wool-passed splenic T cells from C57BL/10 mice were
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FIGURE 1 . Survival of normal (nu/+)
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and athymic nu/nu C57BL/10 mice in-
fected with LP-BM5 MuLV. 10 mice (5 of
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each sex) were 1n~ected lntraperltoneally
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with 0.5 ml LP-BM5 MuLV containing 3
x 10" DUT ecotropic and 4 x 10°FFU
MCF virus at 6-8 wk of age. The two nu/
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nu mice that died at 28 and 32 wk of age
WEEKS AFTER INFECTION
￿
showed no histopathologic evidence of
MAIDS.
injected intravenously into C57BL/10 nu/nu recipients. The splenic T cells were >95%
ThyA + by flow cytometric analysis. All such T cell-reconstituted nu/nu mice showed
evidence of T cell function (see Fig. 3).
Virus Assays.
￿
Mitomycin C-treated suspensions of spleen or lymph node cells were
tested in infectious center assays as described (14). Briefly, expression of infectious
ecotropic MuLV was quantitated by the XC plaque assay of SC-1 cells cocultured with
lymphocytes. Expression of infectious MCF MuLV was quantitated by detection of
infectious centers in mink lung cells using fluorescein-labeled anti-MuLV antibodies.
Values are expressed as logo FFU per 107 cells.
Assays of Immunologic Function.
￿
Serum IgM levels were determined by an ELISA
technique using goat anti-mouse IgM-coated microtiter plate wells. IgM binding was
detected with a peroxidase-labeled goat anti-mouse Ig antibody. B cell proliferation was
stimulated with lipopolysaccharide from E. coli 0111 : B4 or with affinity-purified goat anti-
IgM antibodies. [sH]Thymidine incorporation was determined after a 4-h pulse on the
third day of culture. In vitro antibody responses to the T cell-independent antigens
trinitrophenyl (TNP)-lipopolysaccharide, TNP-B. abortus, and TNP-Ficoll were deter-
mined by the plaque-forming cell assay using TNP-sheep erythrocyte targets as described
(15).
Results
Adult C57BL/10 nu/nu mice or their nu/+ or +/+ littermates (hereafter
nu/+) were infected with LP-BM5 MuLV by intraperitoneal injection (10). The
mice were observed for lymph node enlargement, elevation of serum immuno-
globulin levels, and death. Fig. 1 shows the survival of virus-infected mice. All
mice with normal T lymphocyte function had died by 24 wk after LP-BM5
MuLV inoculation. In marked contrast, 8 of 10 virus-infected nu/nu mice have
continued to survive for over a year. The two nu/nu mice that died at 28 and
32 wk after LP-BM5 MuLV infection had shown no lymphadenopathy or
hypergammaglobulinemia . At necropsy, the first mouse showed a diffuse inter-
stitial pneumonitis and no evidence of lymphoid hyperplasia. The cause of death
is presumed to be viral pneumonitis. The second animal was found to have an
enlarged thymus and mesenteric lymph nodes at necropsy. Immunochemical
staining demonstrated T cell proliferation in these areas. The presumptive cause
of death is a T cell lymphoma in a nu/nu mouse. Such tumors are occasionally
found in older nu/nu mice, and it is impossible to determine whether or not LP-
BM5 MuLV infection contributed to the generation of the lymphoma. No virus-
infected nu/nu mice had detectable inguinal or axillary lymph node enlargement,
whereas prominent lymphadenopathy was apparent by 4 wk after infection in
thymus-bearing littermates. Not only do nu/nu mice survive LP-BM5 MuLV
infection, they show no signs of immunologic abnormalities. Serum IgM levels,
proliferative responses to B cell mitogens, and in vitro antibody responses to TMOSIER ET AL .
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FIGURE 2. Recovery of infectious
ecotropic or MCFMuLV from lymph-
oid tissues of LP-BM5 MuLV-infected
nu/nu (openfigures) or +/+ (closedfig-
ures) mice . Mitomycin C-treated sus-
pensions of spleen (A) or lymph node
(B) cells were tested in infectious center
assays as described in Materials and
Methods . Values are given as logo
PFUper 107 cells (open or closed circles)
or logo FFU per 107 cells (open or
closed squares) .
cell-independent antigens (12) were equivalent in virus-infected and uninfected
nu/nu mice examined at 4, 8, 12, and 16 wk after infection (data not shown) .
The major features of MAIDS thus were absent in virus-infected nu/nu mice .
One potential explanation for the resistance of nu/nu mice to virus-induced
immunodeficiency disease could be a reduced replication of either the ecotropic
or MCF components of LP-BM5 MuLV in nu/nu mice . To evaluate this possi-
bility, spleen and lymph node cells from C57BL/10 nu/nu and +/+ mice were
examined in infectious center assays (13) at various times after inoculation of
LP-BM5 MuLV for the expression of ecotropic and MCF viruses (Fig . 2). At
each time, equivalent levels of ecotropic or MCF virus-producing cells were
detected in lymphoid tissues of mice of either genotype . These results indicate
that LP-BM5 MuLV have no direct effect on the function ofB lymphocytes and,
further, that T cells exert little or no control over virus replication .
Since the nu/nu mutation involves phenotypic manifestations other than the
simple deletion ofTlymphocytes (16, 17), theconclusion thatT cellsare required
for the expression of LP-BM5 MuLV-induced immunodeficiency disease de-
pends upon the demonstration that T cells are sufficient to reconstitute disease
susceptibility of nu/nu mice . Accordingly, groups of nu/nu mice were injected
intravenously with mature splenic T lymphocytes (15), and 2 wk later were
infected with LP-BM5 MuLV . The immunologic status of the mice was deter-
mined 3 and 6 wk after infection . The T cell reconstitution of nu/nu mice
restoredT lymphocyte function, and LP-BM5 MuLV infection of such T cell-
restored mice resulted in clear signs of immunodeficiency disease (Fig . 3) . IgM
levels were elevated, proliferative responses to mitogens were depressed, and
antibody responses to specific antigens were absent in the T cell-reconstituted,
LP-BM5 MuLV-infected group of mice . The in vivo antibody response to TNP-
Ficoll, a T-independent antigen, was normal in all groups of nu/nu mice except
the T cell-reconstituted, virus-infected group (data not shown) . These data
confirm the T cell dependency ofMAIDS .1740
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FIGURE 3. T cell reconstitution of suscepti-
bility to MAIDS in nu/nu mice . C57BL/10
nu/nu mice were injected intravenously with
10 7 nylon wool-purified splenic T cells from
C57BL/10 +/+ donors . 2 wk later, half of the
T cell-reconstituted mice were infected with
LP-BM5 MuLV . At 6 wk after infection, spleen
cell suspensions were prepared from five mice
in each experimental group and assayed for
['H]thymidine incorporation after 3 d culture
with PHA, Con A, or LPS . The designation of
experimental groups is as follows : T-, V-, no T
cell reconstitution, no LP-BM5 MuLV infec-
tion ; T-, V+, no T cell reconstitution, LP-BM5
MuLV infected ; T+, V-,T cell reconstituted,
no LP-BM5 MuLV infection ; T+, V+, T cell
reconstituted, LP-BM5 MuLV infected . Data
are the mean responsesof each group, and the
differences between the T+, V- and the T+,
V+ groups are highly significant (p < 0 .001) .
Discussion
Our data demonstrate that development of MAIDS is totally dependent upon
the presence ofT cells in virus-infected animals . Because spleen and lymph node
cells from T cell-deficient nu/nu mice produce LP-BM5 MuLV viruses at levels
comparable to those ofT cell competent +/+ mice, it appears that cells other
thanT lymphocytes are the primary targets for infection . However, infection of
these cells (which are known to include at least some B lymphocytes and
macrophages [R . A . Yetter, H . C . Morse, D . Spector, and D . E . Mosier, unpub-
lished observations]) is insufficient to cause B cell polyclonal activation or the
failure of B cells to generate specific antibody responses, hallmarks of B cell
dysfunction in MAIDS and AIDS . Because the extent of LP-BM5 MuLV repli-
cation in T cells is not known, it remains uncertain whether or not the critical
contribution to disease induction involves virus-infected or -uninfected T lym-
phocytes . Several products of activated T cells are required for normal B cell
activation (11-13), e.g ., IL-2, IL-4 (BSF-1), and BCGF-II, and it is likely that the
polyclonal B cell activation that heralds the onset of MAIDS cannot proceed
without such T cell-derived lymphokines . The suggestion that virus-induced B
cell abnormalities in MAIDS are T cell-dependent differs from the conclusion
that B cell dysfunction in AIDS reflects a direct effect of HIV on B cells (9) .
Many differencesbetween MAIDS and AIDS, including the etiologic retroviruses
and the infected species could explain this apparent discrepancy, but the obser-
vation that mice selectively depleted of L3T4' helper T cells do not develop
MAIDS (Yetter and Morse, unpublished observations) confirms the required
role of T cells in the murine disease . MAIDS therefore appears to result from a
virally induced distortion of the normal pathways for B cell activation . These
observations raise the question ofwhether there is an early stage in the progres-
sion of AIDS for which intact helper T cell function is required .
Summary
Athymic nu/nu mice were found to be resistant to the immunodeficiency
disease and lethality induced in normal mice by the injection of the LP-BM5MOSIER ET AL.
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mixture of murine retroviruses (LP-BM5 MuLV). Susceptibility to disease induc-
tion was reconstituted by injection of nu/nu mice with purified, mature T
lymphocytes. The extent of viral replication of both the ecotropic and mink cell
focus forming (MCF) components of LP-BM5 MuLV was equivalent in both nu/
nu and normal animals. Retrovirally-induced immunodeficiency disease in mice
(MAIDS) is thus dependent upon the presence of functional T lymphocytes, and
high virus titers in athymic mice have little or no effect on the immune system .
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